Primary |
Product Used For Unknown Indication |
57.4% |
Drug Abuse |
19.2% |
Pain |
9.9% |
Substance Abuse |
1.7% |
Back Pain |
1.5% |
Drug Dependence |
1.5% |
Foetal Exposure During Pregnancy |
1.4% |
Accidental Exposure To Product By Child |
0.9% |
Analgesic Therapy |
0.9% |
Constipation |
0.8% |
Accidental Exposure To Product |
0.6% |
Faeces Hard |
0.6% |
Fibromyalgia |
0.6% |
Neck Pain |
0.6% |
Anaesthesia |
0.5% |
Breakthrough Pain |
0.5% |
Hypertension |
0.5% |
Insomnia |
0.5% |
Alcohol Use |
0.3% |
Anxiety |
0.3% |
|
Drug Abuse |
22.6% |
Drug Dependence |
19.7% |
Substance Abuse |
11.8% |
Overdose |
9.0% |
Road Traffic Accident |
5.7% |
Accidental Overdose |
5.4% |
Drug Ineffective |
3.2% |
Exposure During Pregnancy |
3.2% |
Constipation |
2.2% |
Drug Withdrawal Syndrome |
2.2% |
Nausea |
1.8% |
Pain |
1.8% |
Unresponsive To Stimuli |
1.8% |
Vomiting |
1.8% |
Death |
1.4% |
Foetal Exposure During Pregnancy |
1.4% |
Inadequate Analgesia |
1.4% |
Somnolence |
1.4% |
Feeling Abnormal |
1.1% |
Impaired Driving Ability |
1.1% |
|
Secondary |
Product Used For Unknown Indication |
51.1% |
Pain |
13.5% |
Drug Abuse |
5.8% |
Back Pain |
4.5% |
Breakthrough Pain |
2.4% |
Intervertebral Disc Protrusion |
1.9% |
Constipation |
1.7% |
Meniscus Operation |
1.7% |
Nausea |
1.7% |
Neck Pain |
1.7% |
Sciatica |
1.7% |
Shoulder Operation |
1.7% |
Spinal Fusion Surgery |
1.7% |
Vomiting |
1.7% |
Anxiety |
1.5% |
Foetal Exposure During Pregnancy |
1.5% |
Non-small Cell Lung Cancer |
1.3% |
Cancer Pain |
1.1% |
Substance Abuse |
1.1% |
Arthralgia |
0.9% |
|
Drug Abuse |
11.4% |
Pain |
10.0% |
Substance Abuse |
10.0% |
Vomiting |
10.0% |
Drug Dependence |
8.6% |
Drug Withdrawal Syndrome |
7.1% |
Drug Ineffective |
5.7% |
Unevaluable Event |
5.7% |
Wrong Technique In Drug Usage Process |
5.7% |
Nausea |
4.3% |
Overdose |
4.3% |
Accidental Overdose |
2.9% |
Hallucination |
2.9% |
Weight Increased |
2.9% |
Arthralgia |
1.4% |
Bedridden |
1.4% |
Dehydration |
1.4% |
Dizziness |
1.4% |
Drug Effect Increased |
1.4% |
Drug Rehabilitation |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
48.8% |
Pain |
20.9% |
Breakthrough Pain |
13.6% |
Back Pain |
4.7% |
Axillary Pain |
1.3% |
Musculoskeletal Chest Pain |
1.3% |
Analgesic Therapy |
1.0% |
Sleep Disorder |
1.0% |
Arthralgia |
0.7% |
Back Injury |
0.7% |
Cough |
0.7% |
Drug Abuse |
0.7% |
Hypertension |
0.7% |
Insomnia |
0.7% |
Migraine |
0.7% |
Muscle Spasms |
0.7% |
Neck Pain |
0.7% |
Neuralgia |
0.7% |
Ankylosing Spondylitis |
0.3% |
Antifungal Prophylaxis |
0.3% |
|
Pain |
14.0% |
Vomiting |
10.0% |
Drug Ineffective |
8.0% |
Inadequate Analgesia |
6.0% |
Medication Residue Present |
6.0% |
Unevaluable Event |
6.0% |
Urticaria |
6.0% |
Intentional Drug Misuse |
4.0% |
Nausea |
4.0% |
Product Adhesion Issue |
4.0% |
Pruritus |
4.0% |
Rash |
4.0% |
Surgery |
4.0% |
Weight Decreased |
4.0% |
Weight Increased |
4.0% |
Wrong Technique In Drug Usage Process |
4.0% |
Application Site Rash |
2.0% |
Application Site Vesicles |
2.0% |
Delirium |
2.0% |
Dizziness |
2.0% |
|
Interacting |
|
Pain |
50.0% |
Vomiting |
50.0% |
|